Agalsidase beta 35mg powder for solution for infusion vials
| ID | 407801001 |
|---|---|
| Therapeutic Moiety | Agalsidase beta |
| Name | Agalsidase beta 35mg powder for solution for infusion vials |
| Preferred name basis | rINN - Recommended International Non-proprietary |
| Date of name applicability | 13 Jan 2009 |
| Previous name | Agalsidase beta 35mg powder for solution for injection vials |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Ingredients | Agalsidase beta |
| Form & Route | solutioninfusion.intravenous |
| Drug formulations | Powder for solution for infusion |
| Drug route | Intravenous |
| Control drug | No Controlled Drug Status |